Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Proxida 200µg/2ml


Contraindicated

May be acceptable
Use with caution
Proxida 200µg/2ml :
Type Medicine Authorised
Originator Precedex 200µg/2ml
Agent Droguerie Mercury
Distributor Droguerie Mercury
Laboratory Hikma Pharmaceuticals
Responsible Party Hikma Pharmaceuticals
Origin Jordan
Manufacturer Hikma Farmaceutica
Origin Portugal
ATC N05CM18

Your comment will appear shortly after approval

Different Units By MoH Code

Proxida 200µg/2ml  MoH 10919 :
Form Solution for infusion
Packaging Vial (Type I Glass)
Package Size 25x2ml
Strength 200µg
Public Price 1781079,3 L.L.
Stratum B
NSSF ✔
Quarantine ✘
Reg. Number 161120/1
Submission date 10/11/2020
Registration Year 26/01/2022


Price Comparison

● Country: Lebanon
● Form: Solution for infusion
● Package Size: 25x2ml
● Public Price: 1781079.3 LBP ( 1,781,079.30 LBP )
● Pack size unit used: 25
● Cost/Unit: 71243,17 LBP ( 71,243.00 LBP )
● Pricing Date: 10/01/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Procedural Sedation :
● Cost/Unit: 71243,17 LBP ( 71,243.00 LBP )
● Cost/Day: 71243,17 LBP ( 71,243.00 LBP )
● Cost/Month: 71243,17 LBP ( 71,243.00 LBP )
Sedation of ventilated patients in ICU :
● Cost/Unit: 71243,17 LBP ( 71,243.00 LBP )
● Cost/Day: 71243,17 LBP ( 71,243.00 LBP )
● Cost/Month: 71243,17 LBP ( 71,243.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info